Is Soluble P-selectin Determination a More Reliable Marker of In Vivo Platelet Activation than CD62P Flow Cytometric Analysis?

Is Soluble P-selectin Determination a More Reliable Marker of In Vivo Platelet Activation than CD62P Flow Cytometric Analysis? -

[1]  E. Topol,et al.  Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. , 1998, American heart journal.

[2]  R. Becker,et al.  Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. , 1998, Journal of the American College of Cardiology.

[3]  J. Sixma,et al.  The Origin of P-selectin as a Circulating Plasma Protein , 1997, Thrombosis and Haemostasis.

[4]  J. Loscalzo,et al.  In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Pietrucha,et al.  Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. , 1996, Thrombosis research.

[6]  J. Freedman,et al.  Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube‐H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole , 1995, American journal of hematology.

[7]  G. Silfverstolpe,et al.  The Effects of Transdermal Estradiol and Oral Conjugated Estrogens on Haemostasis Variables , 1994, Thrombosis and Haemostasis.

[8]  L. Guize,et al.  Haemostatic Variables and Menopausal Status: Influence of Hormone Replacement Therapy , 1993, Thrombosis and Haemostasis.

[9]  R. McEver,et al.  GMP-140 mediates adhesion of stimulated platelets to neutrophils. , 1990, Blood.

[10]  D. Wagner,et al.  PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes , 1989, Cell.

[11]  M. Carrai,et al.  Plasma protein binding of ethinyloestradiol: effect of disease and interaction with drugs. , 1989, International journal of clinical pharmacology, therapy, and toxicology.

[12]  J. Thalabard,et al.  Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration. , 1986, The Journal of clinical endocrinology and metabolism.

[13]  E. de Teresa,et al.  Interaction between anticoagulants and contraceptives: an unsuspected finding. , 1979, British medical journal.